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Highlights 19 
 20 
• Modification to methyl hydroxyethyl cellulose produced a novel carbohydrate 21 
(MHCS).  22 
• Modified glucan (MHCS) exhibited consistent biological activities. 23 
• MHCS induced strong respiratory burst in leucocytes without impacting viability. 24 
• MHCS induce the expression of inflammation-related genes in carp immune cells. 25 
• MHCS enhanced the effect of Poly I:C on carp leucocytes. 26 
 27 
Abstract 28 
 29 
The rapid emergence of drug resistance, unfavourable immunosuppression and mounting 30 
evidence to suggest the deleterious accumulation of drug breakdown residues within animal 31 
tissues has driven a strong desire to move away from these current methods of disease 32 
control. Some natural products such as β-glucan, which are extracted from, for example, 33 
plants and fungi, are able to modulate the immune system and increase protection against 34 
diseases. However, these products are heterogeneous and their effects can be variable thus 35 
limiting their applicability and reliability. Carbohydrates were modified via chemical 36 
sulphation and these semi-synthetic, sulphated carbohydrates analysed for their 37 
immunological activity utilising carp pronephric cells and a carp leucocyte cell line (CLC). A 38 
sulphated β(1,4)-glucan, methyl hydroxyethyl cellulose sulphate (MHCS), demonstrated a 39 
stimulatory effect on fish immune cells.  MHCS induced a range of bioactive effects in carp 40 
leucocyte cells whilst not affecting cell viability when cells were exposed for 24h at 41 
concentrations of 1-150 µgml-1. MHCS stimulated the innate immune system where a 42 
significant increase in respiratory burst activity was observed at concentrations 25-250 µgml-1 43 
in comparison to control (sterile water), cellulose ether, MacroGard® and zymosan. Also, 44 
under in mock bacterial and viral infection conditions i.e. Lipopolysaccharide (LPS) and 45 
polyinosinic:polycytidylic acid (Poly(I:C)), MHCS enhanced the immune responses of 46 
pronephric cells by stimulating the respiratory burst activity at concentrations 50 and 150 47 
µgml-1. MHCS also enhanced the expression of cytokines including interleukin 1 beta (IL1β), 48 
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tumor necrosis factor alpha 1 and 2 (TNFα 1,2), interferons alpha 2 (IFN α2) and inducible 49 
nitric oxide synthase (iNOS) in carp pronephric cells. It is proposed that this new semi-50 
synthetic carbohydrate is a potential candidate for the development of a new generation of 51 
immunostimulants and adjuvants for use in vaccination strategies in aquaculture. 52 
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1. Introduction 53 
 54 
Aquaculture is a rapidly developing sector in animal production; however infectious 55 
diseases remain a major obstacle to the expansion of this industry. The widespread use of 56 
antibiotics and chemotherapeutics has conventionally been deployed to ameliorate 57 
undesirable infections. The rapid emergence of drug resistance, unfavourable 58 
immunosuppression and mounting evidence to suggest the deleterious accumulation of drug 59 
breakdown residues within animal tissues such as Microcystin-LR in Yellow Perch (Perca 60 
Flavescens) (Dyble et al., 2011), has driven a strong desire to move away from these current 61 
methods of disease control, thus alleviating their associated negative environmental and 62 
potential health-associated impacts (Anderson, 1992). Routine vaccination, used to strengthen 63 
the immune system in the fish and protect against infection, has emerged as an effective and 64 
economically viable means of disease control although to-date, many infectious diseases of 65 
worldwide importance are not currently preventable by vaccination programmes.  66 
Recent research has concentrated on the development of natural disease control strategies, 67 
which bolster the immune system of the fish through the administration of 68 
immunomodulatory compounds (Maudling, 2006). Such immunomodulators are able to 69 
regulate the immune system through their innate ability to stimulate and/or suppress various, 70 
distinct components within the immune system of fish (Zapata et al., 1997). An example of 71 
an immunomodulatory agent that has found widespread use in aquaculture is the 72 
carbohydrate immunostimulant, β(1,3 ± 1,6)-glucan. These naturally derived carbohydrates 73 
act by enhancing both the innate and adaptive immune system. Administration is normally 74 
carried out through injection, although the use of less invasive immersion bath technologies 75 
and/or formulation within fish feeds are the preferred methods of deployment (Herman, 76 
1970).  77 
Beta-glucan, a polysaccharide composed of repeating β-D-glucose monomers linked by 78 
1,3 and 1,6 glycosidic bonds, is obtained from the cell wall of many microorganisms, cereals, 79 
fungi, seaweed and algae. The most frequent sources are baker’s and brewer’s yeasts 80 
Saccharomyces cerevisiae (Novak and Vetvicka, 2008, Petravić-tominac et al., 2010), which 81 
have been investigated in both laboratory and clinical studies.  82 
Natural β-glucans exhibit a variety of immune-related activities that are dependent on 83 
underlying composition and fine structure, molecular weight, linkage type and branching 84 
pattern; these also dictate the varying solubility of this class of molecules (Li et al., 2013). 85 
This structural complexity and their inherent batch-to-batch variability leads to difficulties in 86 
predicting the immunoactivity profile of β-glucans, which are also capable of provoking 87 
undesirable side-effects when such heterogeneous immunomodulants are utilised as feed 88 
supplements or adjuvants. Both the Centre for Veterinary Medicine (CVM) and the Food and 89 
Drug Administration (FDA) in the United States have implemented several requirements, 90 
which must be adhered to for regulatory approval of aquaculture feeds and drugs. These 91 
requirements includes general examinations i.e. the determination of physicochemical 92 
parameters (e.g. pH), homogeneity, the presence of foreign particles, or microbial 93 
contamination (e.g. Salmonella, Coliform and Vibrio) and the detection of heavy metal 94 
contaminants (e.g. lead, cadmium and mercury). And special examination parameters include 95 
both qualitative and quantitative testing to elucidate an in-depth structural analysis of the 96 
products. Therefore, it is desirable that any immunomodulatory agent, which is to be 97 
formulated with animal feed, or deployed as a drug, has an identifiable structure that can be 98 
reproduced in a facile manner, free from batch-to-batch variation. 99 
Natural polysaccharides can be augmented by sulphation, thereby producing physically 100 
and chemically modified polymers to assist the development of new biomaterials. The 101 
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aforementioned modifications may bestow important therapeutic and biological activities, 102 
examples being the modulation of coagulation by sulphated oat β-glucan (Chang et al., 2006), 103 
the antitumor potential of sulphated α-(1-3)-D-glucan obtained from the fruiting bodies of 104 
Ganoderma lucidum (Zhang et al., 2000) and microbial invasion blocking, e.g. HIV with 105 
sulphated curdlans (Yoshida et al., 1995), or sulphated Konjac glucomannan (Bo et al., 106 
2013). These bioactive carbohydrates are dependent upon the presence of sulphate groups 107 
that play an important role in a variety of regulatory and modulatory processes, combined 108 
with binding and recognition events between specific carbohydrate structures (negatively 109 
charged sulphated group) and their protein partners (usually positively charged peptide 110 
sequences). Binding is affected by the presence of suitable polar groups, the degree of 111 
sulphation, associated cations, molecular weight and the chain conformation of the 112 
polysaccharides (Toida et al., 2003, Bo et al., 2013). 113 
The mechanism of action of sulphated carbohydrates in carp is currently unknown but, it 114 
seems likely that at least in part, it is the result of the ability of sulphated carbohydrates to 115 
mimic the endogenous glycosaminoglycan (GAG) polysaccharides. The GAGs are naturally 116 
occurring, sulphated carbohydrates that are well conserved through evolution, with GAG 117 
species identified in bacteria, fish, reptiles, molluscs, arachnids, insects and mammals (Volpi, 118 
2005). Numerous, distinct roles for the GAG class of polysaccharides have been elucidated in 119 
recognition, binding, regulation and modulation of many proteins, including those involved in 120 
the hosts immune system (Skidmore et al., 2008, Rudd et al., 2010a). Indeed, growing 121 
evidence suggests that the physiological role of heparin, a pharmaceutical anticoagulant, is 122 
most likely to be in an immunomodulatory capacity and not the antithrombotic capacity for 123 
which it is best known. Previous work by the authors has demonstrated that semi-synthetic, 124 
sulphated carbohydrates can mimic the biological activities of the glycosaminoglycan (GAG) 125 
class of naturally occurring, sulphated carbohydrates (Rudd et al., 2010b). This study has pre-126 
screened an extant library of sulphated carbohydrates, acting as GAG analogues, which have 127 
been shown previously to possess favourable bioactivity in biological systems known to be 128 
modulated by GAGs (Rudd et al., 2010b, Boyle et al., 2017, Skidmore et al., 2017). The 129 
constituent sulphated glycans of the library resource cover a wide spread of chemically 130 
diverse sequence-space (including chemically sulphated β-glucans), and this study as 131 
identified a sulphated β(1,4)-glucan, methyl hydroxyethyl cellulose sulphate (MHCS), as a 132 
potential candidate for favourable immunomodulation in aquaculture with future potential as 133 
an adjuvant. Furthermore, the negligible cytotoxicity of this carbohydrate-based candidate 134 
has been demonstrated, along with its favourable immunostimulatory potential within the 135 
inflammatory response of relevant fish cells. 136 
 137 
 138 
  139 
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2. Materials and Methods 140 
 141 
2.1 Preparation of MacroGard®, zymosan and cellulose ether immunostimulants 142 
 143 
Concentrations of MacroGard® (Biorigin; a bakers’ yeast extract containing 60% of β-144 
1,3:β-1,6 glucan), zymosan (Sigma, Z4250; a β-1,3 linked glucan) and cellulose ether 145 
(Tylose) (Sigma 93802; a linear, β-,1,4 linked glucan) were prepared as described by Vera-146 
Jimenez et al. (2013). Owing to the innate insolubilities of the parental material appropriate 147 
concentrations of the aforementioned carbohydrates were made-up in sterile-filtered water 148 
(Sigma, W3500) and sonicated twice for 30 s (Sonics Vibra-cell, power setting 6). To ensure 149 
sterility, the stock solution was heated to 80ºC for 20 min prior to incubation at 19 ± 1ºC. 150 
 151 
2.2 Preparation of pathogen associated molecular patterns (PAMPs)  152 
 153 
LPS from E.coli 0111:B4 strain (Invitrogen) and Poly(I:C) (a synthetic analogue of 154 
dsRNA; Invitrogen), were prepared as per the manufacturer’s instructions and diluted to the 155 
required concentration with sterile-filtered water.     156 
 157 
2.3 Preparation of semi-synthetic sulphated carbohydrate based immunostimulants 158 
 159 
Semi-synthetic carbohydrates were sulphated by a modified version of the chlorosulfonic 160 
acid (CSA) sulphation protocol as described by Yoshida et al. (1995), which modifies 161 
amenable hydroxyls. Briefly, the powdered precursor carbohydrates (0.5 g) were dissolved in 162 
ice-cooled 5 ml dimethylformamide (Sigma), 10 ml pyridine (VWR) and 1 ml chlorosulfonic 163 
acid (Sigma). The mixtures were heated to 95 ̊C for 2 h, cooled over ice and slowly 164 
neutralized with sodium hydroxide (50% w/v; VWR). Ethanol precipitations were performed 165 
in saturated sodium acetate (Sigma), overnight at 4 ̊C. Precipitates were dissolved in 166 
deionized water and dialysed (Mw cut off ˃ 7 kDa; VWR) for 72 h against HPLC grade 167 
water (VWR). The sulphated carbohydrates were lyophilised and resuspended in sterile 168 
filtered water at appropriate concentrations prior to use. Confirmation of sulphation and the 169 
degree of sulphation of bioactive saccharides was achieved using sodium rhodizonate, based 170 
on the method described by Terho and Hartiala (1971) [supplementary data, Figure 1]. 171 
Further evidence of precursor modification was obtained using Attenuated Total Reflection 172 
Fourier Transform Infrared (FTIR-ATR) spectroscopy [supplementary data, Figure 2]. 173 
 174 
2.4 In vitro Carp leucocytes cell line culture. 175 
 176 
Carp leucocytes cell lines (CLCs) is a permanent cell line established from peripheral 177 
blood mononuclear cells obtained from a normal, non-leukemic, non-virally infected 178 
common carp. CLC morphology characterise with an epithelial like shape and exhibiting 179 
functions similar to monocytes and macrophages including adherence to plastic and 180 
phagocytosis of iron particles (Faisal and Ahne, 1990). CLC exhibited respiratory burst 181 
activity after stimulation with Phytohaemagglutinin (PHA) and LPS and this was similar to 182 
head kidney macrophages responses (Koumans-van Diepen et al., 1994). CLC suitability for 183 
studies on macrophage activation, and as in vitro model to study the immune responses of 184 
fish was concluded in both studies by Weyts et al. (1997) and Vidal et al. (2009). In addition, 185 
the CLC stimulate leukocyte proliferation by producing interleukin-1like factors (Weyts et 186 
al., 1997).  The CLC line were kindly provided by Wageningen University, The Netherlands 187 
and were grown at 27°C and 5% CO2 in L-glutamine free RPMI (Sigma) modified with 5% 188 
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(v/v) foetal bovine serum (Sigma), 2.5% (v/v) heat-inactivated pooled carp serum, 50 U/ml 189 
penicillin-G, and 50 mgml-1 streptomycin (Sigma, P4458); this modified medium referred to 190 
hereafter as CLC RPMI+. Cultures were split (1:3 v/v) when reaching 80% confluence; 191 
culture medium was replenished every 3 days. The trypan blue exclusion assay (Howard and 192 
Pesch, 1968, Hauton and Smith, 2004) was used to determine cell viability and only cell 193 
suspensions with at least 95% viability were used for experimentation.  194 
 195 
2.5 Preparation of pronephric cell suspension  196 
 197 
Common carp, Cyprinus carpio (Fair Fisheries, Shropshire, UK), were maintained in 198 
black plastic tanks with recirculating water at 15 °C and pH 7, and kept on a 12 h:12 h, light: 199 
dark cycle. Approximately 25 fish were kept in each tank and were fed daily on commercial 200 
pelleted feed that lacked an immunostimulant additive (Tetra GmbH, Germany). The 201 
pronephros was removed from 5 carps (89.6 ± 12.4 g), which had been sacrificed previously 202 
by a lethal dose (~ 0.2% v/v) of 2-phenoxyethanol (Sigma). Blood was collected from the 203 
caudal vein before dissection. The isolated pronephros was placed in modified RPMI medium 204 
on ice, under sterile conditions and a cell suspension was prepared using a modification of the 205 
procedure described by Kemenade et al. (1994). Briefly, pronephros tissue was disrupted 206 
gently through a sterile cell strainer with 100 µm pore diameter (BD Falcon) in 1 ml of 207 
modified RPMI medium that comprised RPMI supplemented with 0.3 gL-1 L-glutamine 208 
(Sigma), 0.5% (v/v) sterile water, 0.05% (v/v) heat-inactivated pooled carp serum, penicillin 209 
(50 U/ml), and streptomycin (50 µgml-1) (Sigma); this modified medium referred to hereafter 210 
as RPMI+. A non-continuous Percoll gradient (Sigma) was used to isolate leucocytes, which 211 
were collected at the interphase between densities 1.02 gml-1 and 1.08 gml-1, washed three 212 
times with RPMI+ and centrifuged at 4 ̊C (800 g; 10 min). 213 
  214 
2.6 MTT cell proliferation assay  215 
 216 
Potential toxic effects on cell proliferation of administered semisynthetic, sulphated 217 
carbohydrates were determined utilising the tetrazolium salt, 3-4,5 dimethylthiazol-2,5 218 
diphenyl tetrazolium bromide (MTT) assay and compared to other immunostimulants. 219 
Briefly, a serial dilution of the test carbohydrate (1-150 µgml-1) was prepared and added to 220 
CLCs (2 × 104 cells in 100 µl per well) in a 96 multiwell plate (Sarstedt). A negative control 221 
comprising 5 µl sterile water and positive controls comprising 50 µgml-1 of MacroGard® and 222 
zymosan were also included. After 24 h the MTT assay was performed by adding 10 µl per 223 
well of the MTT solution (5 mg of MTT; Sigma) dissolved in 1 ml of PBS (Life 224 
technologies). The plate was then incubated for 4 h at 27 ˚C with 5% CO2, the supernatant 225 
discarded, the cells solubilised with 100 µl of dimethyl sulfoxide (Fisher) and the relative 226 
levels of proliferation measured indirectly by spectrophotometry at a λabs of 540 nm (Ferrari 227 
et al., 1990).  228 
 229 
2.7 Trypan blue cell viable cell count assay  230 
 231 
Trypan blue cell viability assays were conducted with and without the addition of 232 
semisynthetic, sulphated carbohydrate addition and other relevant immunostimulants. CLC 233 
lines (2 × 105 cells in 1 ml of CLC RPMI+ medium) were distributed in 24 wells plates and 234 
stimulated by adding 15 µl per well of carbohydrate sample at 1, 2.5, 50, 150 µgml-1. A 235 
negative control comprising 15 µl per well of sterile water and a positive control comprising 236 
15 µl per well of MacroGard® at a concentration of 50 µgml-1 were also included. After 24 h 237 
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incubation at 27 ̊C and 5% CO2, the culture medium was aspirated, and the cells washed once 238 
with pre-warmed CLC RPMI+ medium. Cells were then detached by adding 250 µl per well 239 
of 0.25x Trypsin-EDTA (Sigma) for 1 min, washed 3 times with 500 µl of CLC RPMI+ 240 
medium, centrifuged at 750 g for 5 min at 19 ± 1 ̊C and the supernatant discarded. The cell 241 
pellet was re-suspended in 500 µl of fresh CLC RPMI+ and viable cells were determined 242 
using trypan blue solution (0.4% w/v).   243 
 244 
2.8 Respiratory burst activity screen 245 
 246 
The NBT assay was performed as described by Vera-Jimenez et al. (2013) to determine 247 
respiratory burst activity. Briefly, CLCs were placed in CLC RPMI+ with the exception that 248 
the RPMI medium used was free of phenol red (Sigma). A cell monolayer was formed at the 249 
bottom of the flat 96 multiwell plate (Sarstedt), which were incubated at 27C˚ in 5% CO2 for 250 
2-3 h. The supernatants were discarded, the cells washed with phenol red free Hank’s 251 
balanced salt solution (HBSS) (Sigma) and 160 µl of CLC RPMI+ containing NBT at 1 252 
mgml-1 (Sigma) was added to each well. The respiratory burst activity was induced by adding 253 
5 µl of increasing concentrations of test solutions containing either MacroGard® (1-150 µgml-254 
1), zymozan (1-150 µgml-1), methyl hydroxyethyl cellulose (2.5-250 µgml-1) or the sulphated 255 
derivative of the latter (MHCS; 1-250 µgml-1). Poly(I:C) (100 µgml-1) and LPS (50 µgml-1)  256 
were also assayed as non-carbohydrate controls. After incubation at 27˚C in 5% CO2, the 257 
supernatants were decanted, the cells fixed with ice cooled methanol (100 µl, 3 min) and the 258 
plates left to air dry. The membranes of the phagocytic cells were solubilised with 120 µl 259 
KOH (2 M) and 140 µl of DMSO added to solubilise the blue formazan. The reduction of 260 
NBT was measured spectrophotometrically at λabs of 620 nm.  261 
 262 
2.9 Carbohydrate based modulation of immune-associated gene expression 263 
 264 
Pronephros cells prepared from 3 fish individually at 4 × 106 cells per well, in 2 ml were 265 
cultured in 6 well plates (Sigma) and exposed to 60 µl of either MacroGard® (50 µgml-1), 266 
LPS (50 µgml-1), Poly(I:C) (100 µgml-1) and MHCS (50, 150 µgml-1). Cells were 267 
subsequently harvested after 6, 12 or 24 h incubation at 27 ̊C with 5% CO2, using 0.25x 268 
Trypsin-EDTA solution, washed 3 times with pre-warmed PBS and collected by 269 
centrifugation (800 g for 10 min at 4 ̊C). 270 
RNA was extracted from cell pellets using an RNeasy kit (Qiagen) and cDNA formed 271 
using the M-MLV RT kit (Invitrogen). Briefly, a mixture of 500 ng of RNA sample, 1 µl of 272 
50 µM random hexamers, 1 µl 10 mM dNTPs and 4.5 µl of DEPC water were heated at 65 ̊C 273 
for 5 min before immediate cooling on ice. After a brief centrifugation, 4 µl of 5X First-274 
Strand buffer, 2 µl of 0.1 M DTT and 1 µl of RNaseOUT™ recombinant ribonuclease 275 
inhibitor (40 units/ µl; Invitrogen) were added and mixed gently. The mixture was heated at 276 
37 ̊C for 2 min and 1 µl (200 units) of M-MLV RT enzyme added before mixing thoroughly. 277 
The reverse transcriptase reactions were carried out after the samples were incubated at 25 ̊C 278 
for 10 min followed by 50 min at 37 ̊C, then enzymes were heat inactivated by incubation at 279 
70 ̊C for 15 min. Samples were diluted 1:10 (v/v) with DEPC treated water and stored at -20 280 
ºC. 281 
Carp specific primers were used to determine the expression levels of IL1β, TNFα1, 282 
TNFα2, iNOS and IFNα2 genes (Table 1); the ribosomal 40S gene was used as a 283 
housekeeping gene (Miest et al., 2012). The PCR reactions were carried out in 96 well PCR 284 
plates (Applied Biosystems, MicroAmp®). Briefly, 2 µl of cDNA were added to 10 µl 285 
SensiFAST, (Bioline, BIO-92020), 0.8 µl of 10 µM forward and reverse primers respectively 286 
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(reaction mixture final concentration equal to 400 nM) and made up to 20 µl with DEPC 287 
treated water (Invitrogen). The PCR plate was centrifuged (660 g, 4 min) (Boeco) prior to 288 
analysis. A cycling procedure was carried out with 1 cycle at 95°C for 2 min, 40 cycles at 289 
95°C for 5 sec and 30 sec at 62°C. The melting curves of the PCR products were determined 290 
after each run between 60 and 95°C. The ∆∆Ct method (Livak and Schmittgen, 2001) of 291 
targeted genes were normalised against the reference gene 40S, and the x-fold change 292 
calculated relative to the control group for each time point. 293 
 294 
2.10 Statistical analysis  295 
 296 
Statistical analyses were carried out using GraphPad Prism 5 and SPSS 21, with all data 297 
presented as the mean ± standard error. Data were tested for normality and equal distribution 298 
of variance. A one-way analysis of variance (ANOVA) and Tukey’s post-hoc test were 299 
performed on the bioactivity data of MHCS with regard to cell proliferation, viability and 300 
ROS production. A two-way analysis of variance (ANOVA) and post-hoc Bonferroni’s 301 
multiple comparisons test were used in the comparison experiments between semi-synthetic 302 
sulphated carbohydrates and different immunostimulants. Gene expression data were 303 
normalised using a Log10 transformation prior to a two-way ANOVA prior to conducting 304 
Bonferroni post-hoc test analyses. Significance was defined as p ≤ 0.05.  305 
 306 
 307 
 308 
 309 
 310 
 311 
 312 
 313 
 314 
 315 
 316 
 317 
 318 
 319 
 320 
 321 
 322 
 323 
 324 
 325 
 326 
 327 
 328 
 329 
 330 
 331 
 332 
 333 
 334 
 335 
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3. Results 336 
 337 
3.1 The effect of MHCS on cell viability & proliferation  338 
 339 
The MTT cell proliferation assay demonstrated that the MHCS was not cytotoxic to the 340 
CLC line over the concentration range screened. Indeed, at concentrations of 1 and 2.5 µgml-1 341 
MHCS promoted a significant increase (p ≤ 0.0011, p ≤ 0.002, respectively) in cell 342 
proliferation (Figure 1). The trypan blue exclusion assay confirmed this observation and 343 
supported the significant increase (p ≤ 0.026) in cell growth after treatment to 2.5 µgml-1 of 344 
MHCS (Figure 2). 345 
 346 
3.2 MHCS induced respiratory burst activity   347 
 348 
Statistical analysis revealed a clear trend and significant increase in the respiratory burst 349 
activity of CLC cells after treatment with MHCS (F = 68.668, p < 0.0001). The 350 
concentration dependency effect of MHCS increased significantly (p ≤ 0.022) at 25, (p ˂ 351 
0.0001) 50, 75, 150 µgml-1 and at the latter concentration, induced an increase in respiratory 352 
burst activity 4.5x greater than that of the control, 5 µl sterile water (Figure 3). 353 
The respiratory burst activity in CLCs after treatment to methyl hydroxyethyl cellulose 354 
and MHCS confirmed that the modification of the polysaccharide by chemical sulphation 355 
conferred favourable bioactivity on the parental molecule (Figure 4). The levels of cell 356 
respiratory burst activity were significantly dependent upon the carbohydrate type (F = 26.24, 357 
p ˂ 0.0001) and their concentrations (F = 38.23, p ˂ 0.0001). The Bonferroni test revealed 358 
significant differences (p ˂ 0.001) between the modified and precursor carbohydrates at 359 
concentrations between 25-250 µgml-1, suggesting that the addition of sulphate moieties 360 
affects the biological activity of the cellulose ether. MHCS promoted the respiratory burst 361 
activity of CLC cells (p < 0.0001) in comparison to the control. The results further support 362 
the data presented in Figure 3.  363 
Experiments on the respiratory burst activity of CLC line was extended to include 364 
MacroGard® and zymosan in comparison with the MHCS at concentrations in the range of 1-365 
150 µgml-1 for 24 h. The assay demonstrated that the type of carbohydrate (F = 834.8, p < 366 
0.0001), the concentration (F = 211.4, p < 0.0001) and the interaction of these two factors (F 367 
= 172.3, p < 0.0001) significantly influence the reactive oxygen species induced in CLC cells 368 
(Figure 5). The effect of MHCS was significant in comparison to MacroGard® and zymosan 369 
at concentrations of 25, 50, 100 and 150 µgml-1 (all at p ˂ 0.0001). The chemically modified 370 
carbohydrate MHCS, stimulated CLC respiratory burst activity and presented a significant 371 
increase at concentrations ≥25 µgml-1 when compared against control (5 µl sterile water) (p < 372 
0.0001).  373 
 374 
3.3 Pathogen associated molecular patterns (PAMPs) and MHCS in pronephric cells 375 
 376 
In order to determine whether MHCS treatment increased the immune response of 377 
pronephric cells under mock infection conditions, the level of reactive oxygen species (ROS) 378 
and effect on cell viability were determined post treatment to LPS and Poly(I:C) (Figure 6 379 
and 7). ROS production in cells was significantly augmented (p ˂ 0.0001) at 50 and 150 380 
µgml-1 of MHCS irrespective of LPS treatment, when compared to the control (5 µl sterile 381 
water) (Figure 6 A). The treatment of pronephric cells with MHCS did not perturb cell 382 
viability at both concentrations either alone, or in combination with LPS (Figure 6 B). 383 
Treatment with MacroGard® at 50 and 150 µgml-1 alone, or with LPS, did not affect the 384 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10 
 
production of ROS. However, a significant decrease in cell viability was observed, when 385 
compared to control, for cells treated with MacroGard® at 50  µgml-1 with LPS (p ˂ 0.0001), 386 
MacroGard® alone at 150 µgml-1 (p = 0.024) and MacroGard® at 150 µgml-1 with LPS (p = 387 
0.004). Significant differences (p = 0.015) between MacroGard® at 50 µgml-1 and 388 
MacroGard® supplemented with LPS were also observed (Figure 6 B).  389 
Treatment with Poly(I:C) induced a significant increase in ROS production alone (p = 390 
0.0002) and in combination with either MacroGard® or MHCS (p ˂ 0.0001) when compared 391 
to the control (5 µl sterile water) (Figure 7 A). The production of ROS in response to 392 
MacroGard® treatment at 50 and 150 µgml-1 had no effect, however when exposed with 393 
Poly(I:C), the ROS levels increased and were significantly different (p = 0.005, p ˂ 0.0001 394 
respectively) to MacroGard® alone. Both MHCS alone, and in the presence of Poly(I:C), 395 
induced highly significant increases in ROS production in comparison to the control (p ˂ 396 
0.0001; Figure 7 A). Interestingly, stimulation with MHCS at both concentrations induced a 397 
significant increase in ROS production of Poly(I:C) treated cells when compared to their 398 
respective concentrations of MHCS without Poly(I:C) and Poly(I:C) alone (Figure 7 A). The 399 
MTT assay shows no significant differences in cell proliferation, and hence viability in all 400 
treatment groups in comparison to the relevant control (Figure 7 B).   401 
 402 
3.4 Immune gene expression in pronephric cells 403 
 404 
The expression levels of the inflammatory cytokines IL1β and TNFα1 were increased 405 
significantly post treatment with MHCS (Figure 8). IL1β expression was up-regulated 406 
significantly (p ˂ 0.0001) after 6 h post treatment at both MHCS concentrations and 407 
remained up-regulated after 12 (p = 0.01) and 24 h (p = 0.03) post treatment to MHCS at a 408 
concentration of 150 µgml-1. While TNFα1 expression increased significantly after 6 h post 409 
treatment with both MHCS at 50 µgml-1 (p = 0.015) and 150 µgml-1 (p = 0.0001). Only 410 
MHCS at 150 µgml-1 affected the TNFα1 expression at 12 h (p = 0.012) and 24 h (p = 0.008) 411 
post treatment. However, the expression of TNFα2 was up-regulated significantly only at 6 h 412 
post treatment with MHCS at 50 µgml-1 (p = 0.046) and 150 µgml-1 (p ˂ 0.0001).  413 
MacroGard® induced significant IL1β expression after 6, 12 and 24 h post treatment (p = 414 
0.031, 0.002, 0.021 respectively). Furthermore, a temporal response was observed in the 415 
expression of TNFα1 and TNFα2 at 6, 12 and 24 h post treatment with MacroGard®. The up-416 
regulation was highly significant at all-time points (p ≤ 0.0001) except for 6 h post treatment, 417 
where the expression of only TNFα1 was significant at p = 0.002. In contrast, elevated 418 
expression levels of IL1β, post treatment with LPS, were only induced significantly (p = 419 
0.007) after 6 h post treatment. Furthermore, iNOS expression levels were increased 420 
significantly after 6 h treatment to MHCS, at concentrations of 50 and 150 µgml-1, 421 
respectively (p = 0.019, p ˂ 0.0001). LPS also induced significant (p = 0.017) iNOS 422 
expression at 6 h post treatment. In comparison, MacroGard® induced a late significant (p ˂ 423 
0.0001) iNOS expression at 12 and 24 h post treatment.  424 
Poly(I:C) at 100 µgml-1 had no effect on either the inflammatory cytokines studied nor 425 
upon iNOS expression (Figure 8). However, the expression levels of IFNα2 were up-426 
regulated significantly at all-time points studied after treatment to Poly(I:C) at 100 µgml-1 (p 427 
˂ 0.0001; Figure 8).   428 
 429 
  430 
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4. Discussion 431 
 432 
The results show that a modified carbohydrate polymer such as MHCS can be generated 433 
with important biological activates and immunostimulatory effects in carp. Although, there 434 
are several methods to induce glucan modifications, sulphation has the strongest effects on 435 
biological function (Han et al., 2008). Previous studies in other non-fish systems have 436 
suggested that the sulphation process may alter the chemical and biological properties of 437 
glucans. For example, sulphated Konjac glucomannan, induces a high anti-HIV activity in 438 
the MT-4 cell line similar to the acquired immune deficiency syndrome (AIDS) drug (Bo et 439 
al., 2013). In another investigation, the presence of a sulphate group on the lentinan structure 440 
caused significant increases in antioxidant activity (Feng et al., 2010). Furthermore, rice bran 441 
β-glucan that was subjected to sulphation had a significant difference to the native oat glucan 442 
in molecular weight, solubility, viscosity and exhibited anticoagulant activity in rat blood 443 
(Chang et al., 2006).  444 
The immune system recognises immunostimulants by the presence of pathogen 445 
recognition receptors (PRRs) that are present on the outer membrane of the immune cells. 446 
This recognition leads to activation of the immune cell and enhancement of their responses, 447 
which usually comprises an increase in their bactericidal activities, including the stimulation 448 
of phagocytosis, leucocyte migration and the production of cytokines (e.g. IL-1, TNFα), nitric 449 
oxide (NO) and reactive oxygen species (Sakai, 1999). In mammals, phagocytosis, believed 450 
to be the uptake mechanism of β-glucan, leads to their antimicrobial activity by the induction 451 
of  reactive oxygen, and nitrogen species production and lytic enzymes in phagosomes 452 
(Goodridge et al., 2009). Several characteristic phagocytosis receptors on carp macrophage, 453 
including the complement receptor 3 (CR3), Scavenger Receptors (SRs) and C-type lectin 454 
receptor (CLR) superfamilies, and sensing receptors such as TLR2 (Petit and Wiegertjes, 455 
2016) have been recognised as detecting β-glucan. 456 
In addition, several studies have also highlighted the dose effects of β-glucans on cell 457 
cytotoxicity/ viability, for example in an investigation carried out on common carp, a 458 
significant increase in apoptosis occurred when pronephric cells were stimulated with β-459 
glucans at concentrations 500 µgml-1 and higher for 6 h incubation (Miest and Hoole, 2015).  460 
The MHCS was able to trigger several bioactive mechanisms i.e. cell viability, increase 461 
leucocyte number and respiratory burst activity. Interestingly, MHCS promoted a rapid 462 
increase in respiratory burst activity, which started at 25 µgml-1 concentrations and reached 463 
more than four and half times higher than the control at 150 µgml-1. This linear dose/effect 464 
relationship is unusual for an immunostimulant because, often, the effect occurs at certain 465 
intermediate concentrations and disappears, or even becomes toxic at high concentrations 466 
(Kum and Sekkin, 2011). This steep increase in respiratory burst activity did not cause 467 
exhaustion to the immune cells as supported by the viability and cell count assays. This was a 468 
promising result, encouraging the debate whether the modification (sulphation) was the 469 
reason behind this biological effect. In a previous study it was shown that the soluble form of 470 
β (1-3)-glucan had some protective properties against infection in mice. The results of that 471 
study showed an increase in neutrophils in blood stream, enhancement in bone marrow 472 
proliferation and in vitro phagocytic activity to E. coli bacteria (Tzianabos, 2000). 473 
The biological activities of modified carbohydrate MHCS were compared to the 474 
native source (cellulose ether) and different β-glucans. Interestingly, cellulose ether, zymosan 475 
and MacroGard® had no significant effects on CLCs line respiratory burst activity, while 476 
MHCS induced a significant increase in comparison to control and previous carbohydrates at 477 
a concentration equal to and higher than 25 µgml-1. These rapid responses to MHCS 478 
carbohydrate by fish leucocytes might be due to carbohydrate-protein interactions. Sulphation 479 
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provides polysaccharides negative charges at the sulphate groups, which may be interacting 480 
with positive peptide sequence of proteins (Chang et al., 2006). This is in line with the many 481 
biological activities, which have been shown in heparin sulphation such as regulation of 482 
cellular growth and proliferation, cell adhesion, blood coagulation, cell surface binding of 483 
proteins, viral invasion, and tumour metastasis (Rabenstein, 2002).  484 
Glucan solubility not only depends on the degree of polymerisation and branching, 485 
but also on chemical derivations including sulphation (Chang et al., 2006). The degree of 486 
substitution (DS) indicates the average number of sulphate groups attached to a glucose unit. 487 
Sodium rhodizonate assay was used to determine the DS of the sulphated derivative MHCS 488 
and was determined as 1.74 molesµg-1 of disaccharides. This demonstrates that sulphation 489 
was sufficient to induce important biological activities without causing detrimental side-490 
effects e.g. cell death. When the degree of sulphation is high, there is an increased chance of 491 
undesirable anticoagulant activities for modified carbohydrates, e.g. highly sulphated 492 
carbohydrates such as dextran sulphate (degree of sulphation 5.25 molesµg-1 of 493 
disaccharides) has a high anticoagulant activity in human blood (Yoshida et al., 1995). 494 
Although the correlation between sulphation levels and anticoagulant potential is complex it 495 
should be noted that teleost fish coagulation system is fundamentally similar to that of 496 
mammals, in spite of the significant evolutionary distance between these groups (Tavares-497 
Dias and Oliveira, 2009). However, blood coagulation time in fish is shorter in comparison to 498 
mammalian and depend on fish species (Wolf, 1959, Doolittle, 1962, Smit and Schoonbee, 499 
1988).  500 
It is possible that MHCS may form the basis of a new carbohydrate adjuvant in 501 
vaccine production. Therefore, before applying the MHCS to in vivo conditions, the effect of 502 
MHCS under mimicked infection conditions using PAMP immunostimulants were 503 
determined in carp pronephric cells. The results revealed that MHCS induced a significant 504 
increase in respiratory burst activity regardless of the LPS availability. LPS did not induce 505 
respiratory burst activity in pronephric cells when exposed alone, and had no additional 506 
effects on cells when exposed with MacroGard® or MHCS. This is despite the ability of LPS 507 
to stimulate the non-specific and specific immune responses in fish, and its recognitions by 508 
toll-like receptor 2 and 4 (TLR2, TLR4) in immune cells that induce a signalling cascade 509 
leading to the activation of NF-κB and the production of proinflammatory cytokines (Swain 510 
et al., 2008). However, responses to LPS can vary depending upon its source (Bich Hang et 511 
al., 2013), and its effects on macrophage respiratory burst activity appeared to be dose and 512 
incubation time dependent (Solem et al., 1995). Nayak et al. (2011) reported the high 513 
variability of the external polysaccharide region of LPS, and the differences in potency and 514 
spectrum of action of the lipid A components in many Gram-negative bacteria. This might be 515 
the explanation of the difference in the LPS effects on fish immunity, for example Watzke et 516 
al. (2007) noted the low sensitivity of zebrafish immune cells to LPS from Escherichia coli in 517 
comparison to Edwardsiella tarda. In addition, LPS from Aeromonas hydrophila stimulated 518 
carp (Cyprinus carpio) immune responses and enhanced fish protection against another 519 
aromonad Aeromonas hydrophila infection when exposed via intraperitoneal injection and 520 
bathing (Selvaraj et al., 2009).  521 
Both MHCS and Poly(I:C) induced significant increases of the respiratory burst 522 
activity when exposed alone. Also, Poly(I:C) boosted the respiratory burst activity of both 523 
MacroGard® and MHCS treated cells. This might be due to the different uptake pathways of 524 
Poly(I:C), MacroGard® and MHCS. It is well established that Poly(I:C), which is used as a 525 
synthetic viral dsRNA analogue, induce IRF-3 (interferon regulatory factor-3) activation via 526 
the TLR3 (is an endosomal PRR of the innate immunity) and the synthesis of interferon-527 
stimulated genes that restrict virus replication (Wang et al., 2009). While the main receptors 528 
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that are associated with glucans comprise C-type lectin receptor Dectin-1, complement 529 
receptor 3 (CR3), scavenger receptors (SRs), glycolipids or Carbohydrate Binding Module 530 
(CBM) (Legentil et al., 2015, Meena et al., 2012). Poly(I:C) recognition pathway was 531 
observed in pronephric cells of carp, where only Poly(I:C) induced significant up regulation 532 
of IFNα2 expression. IFN-alpha is a type I IFN that has a major role in the first line of 533 
defence against viruses. In mammals, the type I IFN antiviral effect is binding to the IFN-α/β-534 
receptor, which triggers the JAK-STAT signal transduction pathway resulting in expression 535 
of Mx and other antiviral proteins (Robertsen, 2006). The difference in Poly(I:C) and MHCS 536 
uptake pathways might be the reason for the boosting of the immune cells responses more 537 
than when they are exposed alone. 538 
MHCS induced the expression of pro-inflammatory cytokines (IL1β, TNFα1 and 539 
TNFα2), and inducible nitric oxide synthase (iNOS) 6h post treatment and the effect was 540 
dose dependant. Interestingly, the effect of MacroGard® was time dependant and increased 541 
with incubation time. MacroGard® time dependency was also observed by Miest and Hoole 542 
(2015) in vitro, where the pro-apoptotic effect was noted to be time and dose dependent only 543 
with concentrations of ≥ 500 µgml-1 causing apoptosis in carp pronephric leucocytes. 544 
The above information is evidence of the ability of MHCS to be recognised by the 545 
innate immune system through pattern recognition receptors (PRRs) including Dectin-1 (β-546 
glucan receptor (βGR), mannose receptor, complement receptors CR3, Toll-like receptors 2 547 
and 6 (TLRs-2/6), scavenger receptors and lactosylceramide (Gantner et al., 2003, Herre et 548 
al., 2004, Chan et al., 2009, Kim et al., 2011). Glucans binding to the above receptors led to 549 
activation of several pathways and triggers several protection mechanisms i.e. phagocytosis, 550 
induction of pathogen killing activity, production of inflammatory cytokines and chemokines, 551 
and initiate the development of adaptive immunity (Gantner et al., 2003). β-glucan is 552 
involved in the enhancement of mononuclear cells and neutrophil anti-microbial activity, 553 
leading to improve macrophage activity and the proliferation of both monocytes and 554 
macrophages, and the production of proinflammatory molecules such as complement 555 
components, interleukin (IL)-1α/β, TNF-α, IL-2, interferon (IFN)-γ, IL-4 and IL-10 (Chan et 556 
al., 2009, Kim et al., 2011, Li et al., 2013). Different glucans associated with different or 557 
similar receptors on immune cells do not induce the immune response equally. For example, 558 
the scavenger receptors are non-opsonic receptors that have low affinity to attach to anionic 559 
β-glucans, which have been sulphated chemically or originate from natural sources (algae) 560 
(Meena et al., 2012). While Dectin-1 receptor has been identified as a major receptor for β-561 
glucans on mammalian leucocytes (Herre et al., 2004). The solubility and smaller molecule 562 
size of MHCS might result in a rapid engulfment and lysis by the immune cells in 563 
comparison to MacroGard. The adjuvant size determines the ability and speed to diffuse 564 
inside tissues and reach the target. At sizes less than 40 nm, transmission is more rapid than 565 
the large size adjuvant of 100 nm that occurs in polysaccharides, which are transported from 566 
the injection site by dendritic cells to the immune organs (Smith et al., 2013). The new 567 
smaller size MHCS thus has potential to have an increased immunostimulant affect in fish 568 
when compared to the larger size carbohydrates which are currently in use e.g. β-glucan. The 569 
utilisation of this new carbohydrate in an in vivo system is in progress.   570 
 571 
5. General conclusion of the study 572 
 573 
The present study contributes to the development of the use of carbohydrates as 574 
immunostimulants in fish. This represents the first attempt to combine synthetic biochemical 575 
approaches with carbohydrate design to produce a novel carbohydrate that modulates the 576 
immune system at the cellular and molecular level. The MHCS exhibited a range of bioactive 577 
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properties such as the non-cytotoxic effect, and production ROS in immune cells. These 578 
bioactivities were associated with the sulphate group in this carbohydrate structure. Also, 579 
there is the potential to use this modified carbohydrate as an adjuvant in vaccines as it was 580 
able to increase the immune response in mimic infection conditions and up-regulate the 581 
expression of inflammatory cytokines genes.   582 
Therefore, the next step is to trial MHCS and in vivo conditions and evaluate the adjuvant 583 
potency in vaccines against important diseases in aquaculture. 584 
 585 
  586 
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Figure legends 772 
 773 
Figure 1: CLC line viability exposed to serial dilution of modified carbohydrates. Cells at 774 
density (2 × 104 cells per well) stimulated with zymosan = Z, MacroGard® = M at 50 µgml-1 775 
and range of modified carbohydrates concentrations 1 - 150 µgml-1 for 24 h. Statistical 776 
analyses were performed by one-way ANOVA (p ≤ 0.05) and the significant differences 777 
between treatments in comparison to control performed with *: p ≤ 0.05, **: p ≤ 0.01 and 778 
***: p ≤ 0.001. Data represent mean ± SEM of 6 well replicates. 779 
 780 
Figure 2: CLC line count utilised by trypan blue viability assay. Cells were exposed to serial 781 
dilution of modified carbohydrates MHCS (1-150 µgml-1) and MacroGard® at 50 µgml-1 782 
concentration for 24 h. Statistic comparison was performed by one-way ANOVA and the 783 
significant differences between treatments in comparison to control performed with *: p ≤ 784 
0.05. Data represent mean ± SEM of 3 well replicates of 24 well plates. 785 
 786 
Figure 3: Dose dependency effect of modified carbohydrates on CLCs respiratory burst 787 
level. Cell were seeded at (2 × 104 cells per well) and stimulated with zymosan at 50 µgml-1 = 788 
Z, MacroGard® at 50 µgml-1 = M and range of modified carbohydrates at concentration 789 
between 1-150 µgml-1 for 24 h incubation. Statistical analysis one-way ANOVA and Tukey’s 790 
post hoc analysis were used and the differences between concentrations in comparable to 791 
control (non-treated cells) performed with *: p ≤ 0.05, **: p ≤ 0.01 and ***: p ≤ 0.0001. Data 792 
represent mean ± SEM of six well replicates. 793 
 794 
Figure 4: CLCs dose responses to sulphated and non-sulphated MHCS determined by NBT 795 
assay. The cells were distributed at (2 × 104 cells per well) stimulated with a range of 796 
cellulose ether and sulphated cellulose ether (MHCS) at concentrations between 2.5-250 797 
µgml-1 for 24 h. Statistic comparison was performed using two-way ANOVA and Bonferroni 798 
post hoc test at p ≤ 0.05 and the significant differences between concentrations in comparison 799 
to control presented with ***: p ˂ 0.0001, also the comparison between the two treatments at 800 
each concentration presented with ∆∆∆: p ˂ 0.0001. Data represented the mean ± SEM of 6 801 
well replicates. 802 
 803 
Figure 5: Comparison of distinct β-glucan sources and MHCS carbohydrate on CLCs 804 
phagocytic activity. Cells phagocytic activity was measured by NBT assay after cells were 805 
distributed at (2 × 104 cells per well) and simulated with either MacroGard®, zymosan or 806 
MHCS at concentrations 1-150 µgml-1 for 24 h. Statistical analysis was performed by two-807 
way ANOVA and Bonferroni post hoc test (p ≤ 0.05) and the significant differences between 808 
MHCS concentrations in comparison to matched control performed with ***: p ≤ 0.0001. 809 
Data represent mean ± SEM of 6 well replicates. 810 
 811 
Figure 6: Respiratory burst production (A) and viability (B) in carp leucocytes after 812 
treatment to LPS (50 µgml-1), MacroGard® (50 or 150 µgml-1) and MHCS (50 or 150 µgml-1) 813 
both exposed individually and in combination with LPS. Statistical analysis one-way 814 
ANOVA and Tukey’s post hoc analysis were used and the differences between 815 
concentrations in comparable to control (non-treated cells) and the LPS availability was 816 
performed with N.S: not significant, *: p ≤ 0.05, **: p ≤ 0.01 and ***: p ≤ 0.0001. Bars 817 
represent the mean of 3 wells from 5 fish ± SEM. 818 
 819 
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Figure 7: Respiratory burst production (A) and viability (B) in carp leucocytes after 820 
treatment to Poly(I:C) (100 µgml-1), MacroGard® (50 or 150 µgml-1) and MHCS (50 or 150 821 
µgml-1) both exposed individually and in combination with Poly(I:C). Statistical analysis 822 
one-way ANOVA and Tukey’s post hoc analysis were used and the differences between 823 
concentrations in comparable to control (non-treated cells) and the Poly(I:C) availability was 824 
performed with N.S = not significant, *: p ≤ 0.05, **: p ≤ 0.01 and ***: p ≤ 0.0001. Bars 825 
represent the mean of 3 wells from 5 fish ± SEM. 826 
 827 
Figure 8: Effect of different immunostimulant and exposure time on immune gene 828 
expression in carp pronephric leucocytes. Bars represent mean of relative expression 829 
normalized to housekeeping gene 40s ± SEM of three fishes. Two ways ANOVA followed 830 
by Bonferroni post hoc analysis used to compare each treatment to the time matched control 831 
*: p ≤ 0.05; **: p ≤ 0.01 and ***: p ≤ 0.001.  832 
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Tables 833 
 834 
Table1: List of used qPCR primers 835 
Function Gene 
name 
Primers sequences 
Gene bank 
accession 
numbers 
References 
House 
keeping 40S 
FW: 5′ CCGTGGGTGACATCGTTACA 3′ 
AB012087 (Huttenhuis et al., 2006) 
RV: 5′ TCAGGACATTGAACCTCACTGTCT 3′ 
Nitric oxide 
production iNOS 
FW: 5′ AACAGGTCTGAAAGGGAATCCA 3′  
AJ242906 (Huttenhuis et al., 2006) 
RV: 5′ CATTATCTCTCATGTCCAGAGTCTCTTCT 3′ 
Pro-
inflammatory 
cytokines 
IL1β 
FW: 5′ AAGGAGGCCAGTGGCTCTGT 3′ 
AJ245635 (Falco et al., 2012) 
RV: 5′ CCTGAAGAAGAGGAGGCTGTCA 3′ 
TNFα1 
FW: 5′ GAGCTTCACGAGGACTAATAGACAGT 3′ 
AJ311800.2 (Falco et al., 2012) 
RV: 5′ CTGCGGTAAGGGCAGCAATC 3′ 
TNFα2 
FW: 5′ CGGCACGAGGAGAAACCGAGC 3′ 
AJ311801.2 (Falco et al., 2012) 
RV: 5′ CATCGTTGTGTCTGTTAGTAAGTTC 3′ 
Anti-viral 
cytokines IFNα2 
FW: 5′ GATGAAGGTGCCATTTCCAAG 3′ AB376667 (Adamek et al., 2014) 
RV: 5′ CACTGTCGTTAGGTTCCATTGCTC3′ 
 836 
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Figure 3 848 
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Figure 4 853 
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Figure 7 872 
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Supplementary Figure 1: Standard curve for dextran sulphate using the sulphate determination 907 
assay, employing sodium rhodizonate, as described by Terho and Hartiala, Anal. Biochem. 1971, 908 
41(2):471-6. y = 0.2637x – 0.0158; R2 = 0.9674. 909 
 910 
The overall sulphation level for methyl hydroxyethyl cellulose sulphate was 911 
determined by the method of Terho and Hartiala (Anal. Biochem. 1971, 41(2):471-6). 912 
Briefly, dextran sulphate, of a predetermined degree of sulphation, was hydrolysed in 1 M 913 
HCl (100°C for 2 hours) prior to lyophilisation. The dry product was reconstituted in sterile 914 
water (1 mgml-1) and serial dilutions performed (calibration curve) before the addition of 0.1 915 
M CH3CO2H, 50 uM BaCl2, 0.8 mM NaHCO3, 0.14 mM sodium rhodizonate and 3.4 mM L-916 
(+)-ascorbic acid. The solution was incubated for 10 min at 20°C (in darkness) to allow 917 
colour to develop. The absorbance of the solution was ascertained at λabs= 520 nm. The assay 918 
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was repeated for methyl hydroxyethyl cellulose sulphate and the mass of sulphate per gram of 919 
polysaccharide calculated from the dextran sulphate calibrant. 920 
 921 
 922 
 923 
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 946 
Supplementary Figure 2: FTIR-ATR spectra for both the unsulphated (A) and sulphated (B) 947 
methyl hydroxyethyl cellulose polysaccharides within the 400-4000 cm-1 spectral region. 948 
First ((C) and (D)) and second derivative ((E) and (F)) curves are shown, respectively. 949 
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Attenuated total reflectance FTIR spectra were recorded for the MHCS carbohydrate 950 
and the precursor using a Nicolet iS5 IR-TF (Thermo Fisher) spectrometer scanning in the 951 
4000–400 cm-1 region with a spectral resolution of 2 cm-1 over 32 scans. A background air 952 
spectrum was obtained and subtracted from all spectra. All carbohydrate spectra were 953 
recorded using ThermoFisher Omnics software. First and second derivatives of all spectral 954 
data for the precursor and modified polysaccharide were plotted and overlaid using Prism 955 
software (GraphPad Software, Inc.). 956 
